The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kimunhappy, what are you going on about, he is a she, it’s a he. However, if you want to identify as a she, he, then she it is.
Only LSE could end this digital care in the community contract, are you a troll from Sou? I know all my tips went sky high and was stopped from further comment on these hot stocks.
I try to help people make back their losses and up pops this person. Imagine bullying someone into making money, couldn’t make that one up. However, in your own universe you may sit.
Back to the reason LSE, allow us all here, that be to comment on stocks in a positive way.
This drop was unexpected. Obviously the market does remain highly cautious about EML. A few more RNSs soon push us higher. More to be happy (that’s a up tone emotion).
AudibleEnergy. He is a she , for your information and I have a vested interest in this company ..... 30k. You seem to get your kicks out of trying to belittle people , # bully . I’m sorry , but you obviously have issues going on in your life that cause you to behave this way . Therefore, I wish you well and hopefully sometime soon you will resolve those issues . #BeKind
Shares just don't go one way. If you want a quick profit go somewhere else. If you want a long term profit then stay patient and don't look at daily movements
Don’t worry about Kim, he is here to sort me out just another LSE digital care in the community patient.
What’s this drop all about very unexpected.
Lets keep things friendly on here. We are only a couple of months away before we start seeing some some serious results. We have already seen a 40% or so rise in the share price this year. Anybody who has put their money in at this stage has identified a very promising investment. Good luck all. By the end of this year, we should all be patting ourselves on the back.
AudibleEnergy.....#BeKind
Mikebasset, Oops, rather embarrassing. Do, do more research before buy in. :)
sport -yes your correct
Mike,
Emmerson have a main market listing, not AIM....the valuation gap will close as the FS date/submission approaches
Throughout multiple discussions we have had with government bodies and community reps at various levels, it was clear that Khemisset is highly significant in terms of its expected positive impacts for our Moroccan stakeholders, hence the outstanding support that we have received.
latest tweet..
if the value gap stays like this i can see them moving from the AIM to the ASX
Posted earlier on the A.dvf.n forum, but a comparison of EML's current and potential near-term value to other potash miners:
Sifting through old Highfields reports, the November 2014 (A$0.55) share price reflected a market cap of 5% of the combined NPV 10 of the 3 projects at the time, all at scoping study stage (USD 2.169 billion @ AUDUSD 0.82 at the time, 252 million shares). When the FS for Muga came through in Mar 2015, share price shot up to $2.00 or 28% of the project portfolio.
Applying the same multipliers for EML:
At scoping stage....5% NPV10 gives either 6p or 10p (depending upon whether you use the $1.1bln or updated $1.8bln).
Bringing this forward to the FS stage then the value increases to either 35p or 56p (again depending on whether using the $1.1bln or $1.8bln)
So, give the FS is ahead of schedule...within the next 3 months we could be looking at anywhere between a 7x and 11x return on current buy prices!